<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1405-9940</journal-id>
<journal-title><![CDATA[Archivos de cardiología de México]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Cardiol. Méx.]]></abbrev-journal-title>
<issn>1405-9940</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Cardiología Ignacio Chávez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1405-99402025000200154</article-id>
<article-id pub-id-type="doi">10.24875/acm.24000120</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Dificultades en el monitoreo del riesgo cardiometabólico ante el uso crónico de antipsicóticos atípicos para indicaciones no tradicionales, en un hospital de especialidades en Argentina: un estudio cualitativo]]></article-title>
<article-title xml:lang="en"><![CDATA[Difficulties in monitoring cardiometabolic risk in the chronic use of atypical antipsychotics for non-traditional indications, in a specialty hospital in Argentina: a qualitative study]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vivacqua]]></surname>
<given-names><![CDATA[María N.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Grande Ratti]]></surname>
<given-names><![CDATA[María F.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Faccioli]]></surname>
<given-names><![CDATA[José L.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Hospital Italiano de Buenos Aires Servicio de Psiquiatría ]]></institution>
<addr-line><![CDATA[Buenos Aires ]]></addr-line>
<country>Argentina</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Área de Investigación en Medicina Interna Área de Investigación en Medicina Interna ]]></institution>
<addr-line><![CDATA[Buenos Aires ]]></addr-line>
<country>Argentina</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Italiano de Buenos Aires Servicio de Psiquiatría ]]></institution>
<addr-line><![CDATA[Buenos Aires ]]></addr-line>
<country>Argentina</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<volume>95</volume>
<numero>2</numero>
<fpage>154</fpage>
<lpage>162</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1405-99402025000200154&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1405-99402025000200154&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1405-99402025000200154&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Explorar las barreras que obstaculizan el correcto monitoreo de efectos adversos en pacientes con prescripción de antipsicóticos, en un hospital de especialidades médicas en Argentina.  Método: Estudio cualitativo interpretativo de diseño narrativo, con diez entrevistas semiestructuradas individuales a médicos de diversas especialidades, pertenecientes al área de consultorios externos, realizadas entre mayo y noviembre de 2022, con una guía diseñada ad hoc a partir de la bibliografía.  Resultados: Surgieron barreras en las relaciones interpersonales, destacándose la insuficiente duración y la escasa frecuencia de las consultas, problemas de comunicación entre profesionales y de los profesionales con sus pacientes, y dificultades para el trabajo en equipo. Los obstáculos se relacionaron con: 1) escasa comunicación directa; 2) comunicación mediante la historia clínica electrónica (sin acuerdo previo ni confirmación de recepción de mensajes); 3) uso de pacientes como intermediarios para el intercambio de mensajes; 4) desestimar indicaciones de otro profesional sin comunicarse con él; 5) expresar al paciente diferencias de criterios, delegando la responsabilidad sobre las decisiones de su tratamiento; 6) asumir que el monitoreo del antipsicótico lo lleva a cabo otro profesional; 7) jerarquías que obstaculizan la comunicación, y 8) referentes médicos experimentados que abandonan la institución. Estos tópicos están relacionados con cuestiones inherentes del sistema sanitario, principalmente con la escasez de tiempo disponible y la comunicación entre colegas como tarea no remunerada.  Conclusiones: La falta de comunicación condicionada a circunstancias que impone el sistema sanitario puede resultar en malentendidos que derivan en resultados de salud subóptimos. Difundir esta información podría guiar a las organizaciones en el desarrollo de estrategias para mejorar la comunicación y facilitar el trabajo en equipo en entornos hospitalarios.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: To explore the barriers that hinder the proper monitoring of adverse effects in patients prescribed antipsychotics in a medical specialty hospital in Argentina.  Method: A qualitative interpretive study of narrative design with ten semi-structured individual interviews with doctors from various specialties, conducted in outpatient clinics between May and November 2022, with an ad hoc guide based on a bibliography.  Results: Barriers in interpersonal relationships emerged, highlighting the insufficient duration and infrequent consultations, communication problems between professionals and between professionals and their patients, and difficulties in teamwork. The obstacles were related to 1) limited direct communication; 2) communication via electronic medical records (without prior agreement or confirmation of receipt of messages); 3) use of patients as intermediaries for message exchange; 4) disregarding another professional's indications without communicating with them; 5) expressing differing criteria to the patient, delegating responsibility for treatment decisions to the patient; 6) assuming that antipsychotic monitoring is carried out by another professional; 7) hierarchies that hinder communication, and 8) experienced medical referents. These topics relate to inherent healthcare system issues, mainly the lack of available time and communication between colleagues as an unpaid task.  Conclusions: Communication barriers imposed by the healthcare system can result in misunderstandings that lead to suboptimal health outcomes. Sharing this information could guide organizations in developing strategies to improve communication and facilitate teamwork in hospital settings.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Antipsicóticos]]></kwd>
<kwd lng="es"><![CDATA[Monitoreo]]></kwd>
<kwd lng="es"><![CDATA[Comunicación]]></kwd>
<kwd lng="es"><![CDATA[Efectos adversos cardiometabólicos]]></kwd>
<kwd lng="es"><![CDATA[Investigación cualitativa]]></kwd>
<kwd lng="en"><![CDATA[Antipsychotic agents]]></kwd>
<kwd lng="en"><![CDATA[Drug monitoring]]></kwd>
<kwd lng="en"><![CDATA[Communication]]></kwd>
<kwd lng="en"><![CDATA[Cardiometabolic adverse effects]]></kwd>
<kwd lng="en"><![CDATA[Qualitative research]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rizzi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rosset]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Roriz-Cruz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global epidemiology of dementia:Alzheimer's and vascular types]]></article-title>
<source><![CDATA[Biomed Res Int]]></source>
<year>2014</year>
<volume>2014</volume>
<page-range>908915</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mühlbauer]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Möhler]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dichter]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Zuidema]]></surname>
<given-names><![CDATA[SU]]></given-names>
</name>
<name>
<surname><![CDATA[Köpke]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Luijendijk]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2021</year>
<numero>12</numero>
<issue>12</issue>
<page-range>CD013304</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vivacqua]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Abudarham]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Pagotto]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Faccioli]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[[Antipsychotic prescription prevalence and metabolic monitoring of patients under chronic treatment]]></article-title>
<source><![CDATA[Rev Fac Cien Med Univ Nac Cordoba]]></source>
<year>2021</year>
<volume>78</volume>
<page-range>276-82</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reilly]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Ayis]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrier]]></surname>
<given-names><![CDATA[IN]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2000</year>
<volume>355</volume>
<page-range>1048-52</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Doménech-Matamoros]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influence of the use of atypical antipsychotics in metabolic syndrome]]></article-title>
<source><![CDATA[Rev Esp Sanid Penit]]></source>
<year>2020</year>
<volume>22</volume>
<page-range>80-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez-Martínez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Romero-Rubio]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Abad-Pérez]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Descalzo-Cabades]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso-Gutiérrez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar-Fraile]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic syndrome and cardiovascular risk in people treated with long-acting injectable antipsychotics]]></article-title>
<source><![CDATA[Endocr Metab Immune Disord Drug Targets]]></source>
<year>2018</year>
<volume>18</volume>
<page-range>379-87</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Howell]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Yarovova]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Khwanda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rosen]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular effects of psychotic illnesses and antipsychotic therapy]]></article-title>
<source><![CDATA[Heart]]></source>
<year>2019</year>
<volume>105</volume>
<page-range>1852-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Duan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Guan]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glucose metabolism, neural cell senescence and Alzheimer's disease]]></article-title>
<source><![CDATA[Int J Mol Sci]]></source>
<year>2022</year>
<volume>23</volume>
<page-range>4351</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De la Monte]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Wands]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alzheimer's disease is type 3 diabetes-evidence reviewed]]></article-title>
<source><![CDATA[J Diabetes Sci Technol]]></source>
<year>2008</year>
<volume>2</volume>
<page-range>1101-13</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Dagerman]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Insel]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of death with atypical antipsychotic drug treatment for dementia:meta-analysis of randomized placebo-controlled trials]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2005</year>
<volume>294</volume>
<page-range>1934-43</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ko]]></surname>
<given-names><![CDATA[YK]]></given-names>
</name>
<name>
<surname><![CDATA[Soh]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The prevalence of metabolic syndrome in schizophrenic patients using antipsychotics]]></article-title>
<source><![CDATA[Clin Psychopharmacol Neurosci]]></source>
<year>2013</year>
<volume>11</volume>
<page-range>80-8</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists. North American Association for the Study of Obesity</collab>
<article-title xml:lang=""><![CDATA[Consensus development conference on antipsychotic drugs and obesity and diabetes]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2004</year>
<volume>27</volume>
<page-range>596-601</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Budovich]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Claudio-Sáez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Monitoring of metabolic adverse effects associated with atypical antipsychotics use in an outpatient psychiatric clinic]]></article-title>
<source><![CDATA[J Pharm Pract]]></source>
<year>2019</year>
<volume>32</volume>
<page-range>388-93</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Roodbeen]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Vreke]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Boland]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Rademakers]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[van den Muijsenbergh]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Noordman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Communication and shared decision-making with patients with limited health literacy;helpful strategies, barriers and suggestions for improvement reported by hospital-based palliative care providers]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2020</year>
<volume>15</volume>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heritage]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Maynard]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Roter]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Halkowski]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Gill]]></surname>
<given-names><![CDATA[VT]]></given-names>
</name>
</person-group>
<source><![CDATA[Communication in medical care:interaction between primary care physicians and patients]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Cambridge ]]></publisher-loc>
<publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kohn]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Christiaens]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Detraux]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[De Lepeleire]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[De Hert]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gillain]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Barriers to somatic health care for persons with severe mental illness in Belgium:a qualitative study of patients'and healthcare professionals'perspectives]]></article-title>
<source><![CDATA[Front Psychiatry]]></source>
<year>2021</year>
<volume>12</volume>
<page-range>798530</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Jalal]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Paudyal]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Barriers to monitoring and management of cardiovascular and metabolic health of patients prescribed antipsychotic drugs:a systematic review]]></article-title>
<source><![CDATA[BMC Psychiatry]]></source>
<year>2020</year>
<volume>20</volume>
<page-range>1-15</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Urtasun]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Janer Tittarelli]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[PumaráC]]></given-names>
</name>
<name>
<surname><![CDATA[Davenport]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[[Physician's communicational skills. Experience in the medicine department of a pediatric hospital]]]></article-title>
<source><![CDATA[Rev Fac Cien Med Univ Nac Cordoba]]></source>
<year>2021</year>
<volume>78</volume>
<page-range>270-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Corbin]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Corbin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Strauss]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Basics of qualitative research:techniques and procedures for developing grounded theory]]></source>
<year>2008</year>
<publisher-loc><![CDATA[Los Angeles ]]></publisher-loc>
<publisher-name><![CDATA[SAGE]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brody]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Liss]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Wray]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Iovin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Michaylira]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Muthutantri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine:results from two postauthorization safety studies]]></article-title>
<source><![CDATA[Int Clin Psychopharmacol]]></source>
<year>2016</year>
<volume>31</volume>
<page-range>34</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Hanratty]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Morant]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Moncrieff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mental health professionals'views and experiences of antipsychotic reduction and discontinuation]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2019</year>
<volume>14</volume>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<collab>De Gialdino IV</collab>
<source><![CDATA[Estrategias de investigación cualitativa]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[GEDISA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sampieri]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<source><![CDATA[Metodología de la investigación:las rutas cuantitativa, cualitativa y mixta]]></source>
<year>2018</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[McGraw Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Banner]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jensen]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular disease in patients with severe mental illness]]></article-title>
<source><![CDATA[Nat Rev Cardiol]]></source>
<year>2021</year>
<volume>18</volume>
<page-range>136-45</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilsher]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Gibbs]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reed]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Baker]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lindqvist]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient care, integration and collaboration of physician associates in multiprofessional teams:a mixed methods study]]></article-title>
<source><![CDATA[Nurs Open]]></source>
<year>2023</year>
<volume>10</volume>
<page-range>3962-72</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boon]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Mior]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Barnsley]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ashbury]]></surname>
<given-names><![CDATA[FD]]></given-names>
</name>
<name>
<surname><![CDATA[Haig]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The difference between integration and collaboration in patient care:results from key informant interviews working in multiprofessional health care teams]]></article-title>
<source><![CDATA[J Manipulative Physiol Ther]]></source>
<year>2009</year>
<volume>32</volume>
<page-range>715-22</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lyndon]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Holl]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bilimoria]]></surname>
<given-names><![CDATA[KY]]></given-names>
</name>
<name>
<surname><![CDATA[Stey]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Barriers and facilitators to interdisciplinary communication during consultations:a qualitative study]]></article-title>
<source><![CDATA[BMJ Open]]></source>
<year>2021</year>
<volume>11</volume>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Añel Rodríguez]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Aibar Remón]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Martín Rodríguez]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[[Patient participation in its own safety]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2021</year>
<volume>53</volume>
<numero>Supl 1</numero>
<issue>Supl 1</issue>
<page-range>102215</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Banner]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jensen]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular disease in patients with severe mental illness]]></article-title>
<source><![CDATA[Nat Rev Cardiol]]></source>
<year>2021</year>
<volume>18</volume>
<page-range>136-45</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
